Goal: To study the safety and effectiveness of different drugs in treating COVID-19 in outpatients.
- Phase III, randomized, blinded, placebo-controlled trial.
- Subjects in the study will be treated with either a study drug or with placebo.
- Multicenter trial with 2000 subject enrollment goal.
Dr. Francis Riedo, EvergreenHealth Infectious Disease Care